LABA
Indacaterol
Brand names: Onbrez Breezhaler
Adult dose
Dose: 150 micrograms inhaled OD; max 300 micrograms OD
Route: Inhaled
Frequency: OD
Clinical pearls
- COPD; not licensed for asthma monotherapy
- Once-daily LABA
Contraindications
- Severe milk-protein allergy
- Hypersensitivity
Side effects
- Cough
- Tachycardia
- Tremor
- Hypokalaemia
- Headache
- Paradoxical bronchospasm
Interactions
- β-blockers
- QT-prolonging drugs
- Hypokalaemic agents
Reference: BNF; NICE NG115; https://bnf.nice.org.uk/drugs/indacaterol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024